Brief: Initiator Pharma: Draft Data From IPED2015 Study Expected In December
Sept 27 (Reuters) - Initiator Pharma A/S INIT.TE :
* CURRENT BEST ESTIMATE FOR RELEASING DRAFT DATA FROM IPED2015 CLINICAL TRIAL IS DURING
DECEMBER
2019
Source text for Eikon: ID:nWkr2MRzT4
Further company coverage: INIT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD